Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50


Linking NHS data for pediatric pharmacovigilance: Results of a Delphi survey.

Hopf YM, Francis J, Helms PJ, Haughney J, Bond C.

Res Social Adm Pharm. 2015 Jul 2. pii: S1551-7411(15)00123-0. doi: 10.1016/j.sapharm.2015.06.006. [Epub ahead of print]


Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J, Sullivan A, Wilson A, Price D.

Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.


Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.

Pascual S, Feimer J, De Soyza A, Sauleda Roig J, Haughney J, Padullés L, Seoane B, Rekeda L, Ribera A, Chrystyn H.

NPJ Prim Care Respir Med. 2015 Apr 30;25:15018. doi: 10.1038/npjpcrm.2015.18.


Serum periostin in smokers and never smokers with asthma.

Thomson NC, Chaudhuri R, Spears M, Haughney J, McSharry C.

Respir Med. 2015 Jun;109(6):708-15. doi: 10.1016/j.rmed.2015.03.009. Epub 2015 Apr 3.


Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.

McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J.

Respir Med. 2015 Feb;109(2):228-37. doi: 10.1016/j.rmed.2014.12.006. Epub 2014 Dec 30.


'The more you link, the more you risk …' - a focus group study exploring views about data linkage for pharmacovigilance.

Hopf YM, Bond C, Francis J, Haughney J, Helms PJ.

Br J Clin Pharmacol. 2014 Nov;78(5):1143-50. doi: 10.1111/bcp.12445.


Case-finding of chronic obstructive pulmonary disease with questionnaire, peak flow measurements and spirometry: a cross-sectional study.

Mahboub B, Alzaabi A, Soriano JB, Salameh L, Mutairi YA, Yusufali AA, Alsheikh-ali A, Almahmeed W, Haughney J.

BMC Res Notes. 2014 Apr 16;7:241. doi: 10.1186/1756-0500-7-241.


Guidance on handheld inhalers in asthma and COPD guidelines.

Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J.

Respir Med. 2014 May;108(5):694-700. doi: 10.1016/j.rmed.2014.02.013. Epub 2014 Mar 1. Review.


Linked health data for pharmacovigilance in children: perceived legal and ethical issues for stakeholders and data guardians.

Hopf YM, Bond CB, Francis JJ, Haughney J, Helms PJ.

BMJ Open. 2014 Feb 12;4(2):e003875. doi: 10.1136/bmjopen-2013-003875.


Switching from branded to generic inhaled medications: potential impact on asthma and COPD.

Lavorini F, Ninane V, Haughney J, Bjermer L, Molimard M, Dekhuijzen RP.

Expert Opin Drug Deliv. 2013 Dec;10(12):1597-602. doi: 10.1517/17425247.2013.852182. Epub 2013 Nov 14.


Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients.

Price D, Small I, Haughney J, Ryan D, Gruffydd-Jones K, Lavorini F, Harris T, Burden A, Brockman J, King C, Papi A.

Prim Care Respir J. 2013 Dec;22(4):439-48. doi: 10.4104/pcrj.2013.00088.


The distribution of COPD in UK general practice using the new GOLD classification.

Haughney J, Gruffydd-Jones K, Roberts J, Lee AJ, Hardwell A, McGarvey L.

Eur Respir J. 2014 Apr;43(4):993-1002. doi: 10.1183/09031936.00065013. Epub 2013 Oct 31.


Views of healthcare professionals to linkage of routinely collected healthcare data: a systematic literature review.

Hopf YM, Bond C, Francis J, Haughney J, Helms PJ.

J Am Med Inform Assoc. 2014 Feb;21(e1):e6-10. doi: 10.1136/amiajnl-2012-001575. Epub 2013 May 28. Review.


Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.

Price D, Thomas M, Haughney J, Lewis RA, Burden A, von Ziegenweidt J, Chisholm A, Hillyer EV, Corrigan CJ.

Respir Med. 2013 Jul;107(7):987-1000. doi: 10.1016/j.rmed.2013.03.009. Epub 2013 May 3.


Prevalence of common chronic respiratory diseases in drug misusers: a cohort study.

Palmer F, Jaffray M, Moffat MA, Matheson C, McLernon DJ, Coutts A, Haughney J.

Prim Care Respir J. 2012 Dec;21(4):377-83. doi: 10.4104/pcrj.2012.00069.


Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care.

Price D, Chrystyn H, Kaplan A, Haughney J, Román-Rodríguez M, Burden A, Chisholm A, Hillyer EV, von Ziegenweidt J, Ali M, van der Molen T.

Allergy Asthma Immunol Res. 2012 Jul;4(4):184-91. doi: 10.4168/aair.2012.4.4.184. Epub 2012 Apr 6.


Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.

van Schayck OC, Haughney J, Aubier M, Selroos O, Ekström T, Ostinelli J, Buhl R.

Respir Med. 2012 Feb;106(2):189-96. doi: 10.1016/j.rmed.2011.10.017. Epub 2011 Nov 26.


Inhaled corticosteroid/long-acting β₂-agonist combination therapy for asthma: attitudes of specialists in Europe.

Bousquet J, Winchester C, Papi A, Virchow JC, Haughney J, Costa D, Usmani O, Bjermer L, Price D; Global Allergy and Asthma European Network (GA²LEN).

Int Arch Allergy Immunol. 2012;157(3):303-10. doi: 10.1159/000329519. Epub 2011 Nov 1.


Current control and future risk in asthma management.

Sims EJ, Price D, Haughney J, Ryan D, Thomas M.

Allergy Asthma Immunol Res. 2011 Oct;3(4):217-25. doi: 10.4168/aair.2011.3.4.217. Epub 2011 Sep 21.


Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD.

Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Barnes N.

J Asthma Allergy. 2011;4:37-47. doi: 10.2147/JAA.S17709. Epub 2011 Apr 28.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk